Medications for Heart Failure

10 results
  • atorvaliq - atorvaliq suspension

    (Atorvaliq)
    Cmp Pharma, Inc.
    Atorvaliq reduces cardiovascular risk (MI, stroke, angina) in adults with CHD risk factors, established CHD, or type 2 diabetes. Also lowers LDL-C in adults and children 10+ with primary hyperlipidemia, familial hypercholesterolemia, dysbetalipoproteinemia, or hypertriglyceridemia.
  • epaned - enalapril maleate solution

    (Enalapril Maleate)
    Azurity Pharmaceuticals, Inc.
    Epaned treats hypertension in adults and children older than one month to reduce stroke and heart attack risk, symptomatic heart failure to improve survival and reduce hospitalizations, and asymptomatic left ventricular dysfunction to slow progression to overt heart failure.
  • farxiga - dapagliflozin tablet, film coated

    (Dapagliflozin)
    Astrazeneca Pharmaceuticals Lp
    Farxiga is indicated for adults with chronic kidney disease, heart failure, or type 2 diabetes mellitus. It reduces risks of kidney disease progression, cardiovascular death, and heart failure hospitalization, and improves glycemic control in adults and children aged 10+ with type 2 diabetes as an adjunct to diet and exercise.
  • inpefa - sotagliflozin tablet

    (Sotagliflozin)
    Lexicon Pharmaceuticals, Inc.
    INPEFA reduces the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adults with heart failure, or type 2 diabetes mellitus, chronic kidney disease, and other cardiovascular risk factors.
  • jardiance - empagliflozin tablet, film coated

    (Empagliflozin)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    Jardiance reduces the risk of cardiovascular death and heart failure hospitalization in adults. It also slows chronic kidney disease progression, reduces cardiovascular death in type 2 diabetes with established cardiovascular disease, and improves blood sugar control in adults and children aged 10+ with type 2 diabetes.
  • kerendia - finerenone tablet, film coated

    (Finerenone)
    Bayer Healthcare Pharmaceuticals Inc.
    Kerendia reduces risk of kidney disease progression, cardiovascular death, heart attack, and heart failure hospitalization in adults with chronic kidney disease and type 2 diabetes. Also indicated for cardiovascular death and heart failure events in adults with heart failure with preserved or mildly reduced ejection fraction (LVEF ≥ 40%).
  • samsca - tolvaptan tablet

    (Tolvaptan)
    Otsuka America Pharmaceutical, Inc.
    Samsca treats clinically significant hypervolemic and euvolemic hyponatremia (low blood sodium) in adults, including those with heart failure or SIADH, when fluid restriction has failed. Not indicated when urgent sodium correction is needed for serious neurological symptoms.